The market pushed PNV to $4 at a stage where some blue-sky projects seemed on track. e.g. hernia & breast products. To me, short covering is only part of the price story from that period, though I accept this was DWs explanation of events. Regardless, the rapid fall from $4 back to the $2.60 area did coincide with timelines on these projects being pushed out. Then we had COVID etc... Looking forward, the revenue runway for SynPath and MTX may trigger broker revaluations in the next 6 months. Also, DW stated in a recent interview, that our IP profile could look very different in a few years. So to me, the blue-sky potential is unrecognised atm. That's why I tipped $4 plus by June 30 next year.
30th June 2024 Share Price Prediction, page-175
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
0.035(1.76%) |
Mkt cap ! $1.395B | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $1.99 | $1.878M | 928.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 64161 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 27397 | 37 |
View Market Depth
| Last trade - 14.30pm 07/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |